Integrated Diagnostics Holdings plc (FRA:8I8)

Market Cap	273.74M +60.7%
Revenue (ttm)	131.71M +42.9%
Net Income	23.46M +55.5%
EPS	0.04 +55.5%
Shares Out	n/a
PE Ratio	11.67
Forward PE	11.88
Dividend	0.01 (3.33%)
Ex-Dividend Date	Sep 11, 2025

Volume	n/a
Average Volume	n/a
Open	0.4360
Previous Close	0.4480
Day's Range	0.4360 - 0.4360
52-Week Range	0.2320 - 0.7100
Beta	n/a
RSI	38.80
Earnings Date	Apr 8, 2026

About FRA:8I8

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Medical Laboratories
• Founded: 1979
• Employees: 6,309
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8I8

Financial Performance

In 2024, FRA:8I8's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP